Sana Biotechnology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SANA research report →
About the company
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses.
- CEO
- Steven D. Harr
- IPO
- 2021
- Employees
- 194
- HQ
- Seattle, WA, US
Price Chart
- Market Cap
- $1.12B
- P/E
- -4.31
- P/S
- 0.00
- P/B
- 9.31
- EV/EBITDA
- -5.92
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -161.87%
- ROIC
- -78.61%
- Revenue
- $0 · 0.00%
- Net Income
- $-244,166,000 · 8.47%
- EPS
- $-0.96 · 17.24%
- Op Income
- $-190,958,000
- FCF YoY
- 43.58%
- 52W High
- $6.55
- 52W Low
- $2.61
- 50D MA
- $3.21
- 200D MA
- $3.85
- Beta
- 2.16
- Avg Volume
- 3.95M
Get TickerSpark's AI analysis on SANA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Yang Patrick Y | other | 90,000 |
| Jun 4, 26 | Rosiello Robert L. | other | 90,000 |
| Jun 4, 26 | Seitz Michelle | other | 90,000 |
| Jun 4, 26 | REICIN ALISE | other | 90,000 |
| Jun 4, 26 | Mulligan Richard | other | 90,000 |
| Jun 4, 26 | Bishop Hans Edgar | other | 90,000 |
| Jun 4, 26 | Bilenker Joshua H. | other | 90,000 |
| Jun 4, 26 | NELSEN ROBERT | other | 90,000 |
| Apr 6, 26 | Bishop Hans Edgar | other | 7,763 |
| Mar 24, 26 | PATEL DHAVALKUMAR DHIRAJLAL | other | 0 |
Our SANA coverage
Recent articles, reports, and earnings notes.
No research on SANA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SANA report →Similar companies
Peers in the same neighborhood.